Our findings underscore the role of ARG2-enriched CXCR2Hi MDSCs in the pathogenesis of septic lymphopenia and propose ARG2 as a promising therapeutic target for immunomodulation in sepsis. The gene discussed is ARG2; the disease is lymphopenia.